Company Spotlight

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile

Adare Pharmaceuticals

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


WDPrx - Woodfield Pharmaceutical, LLC





Company Headquarters

10863 Rockley Road
Houston, TX 77099
United States

Company Description

WDPrx - Woodfield Pharmaceutical, LLC is a proven and reliable CMO partner specializing in oral solutions, liquid solutions, suspensions and semi-solids. Our established record of commercialization success spans more than 30 years in continual operation built upon a strong foundation of financial strength and stability. Our experienced team provides end-to-end pharmaceutical outsourcing services from Research and Development, Material Procurement, Process Optimization, Formulation and Pharmaceutical Validation to Manufacturing, Analytics Testing, Regulatory Support, Primary and Secondary Packaging and Labeling. The modern facility in Houston, TX is fully-owned. WDPrx is cGMP and DSCSA-compliant, supports full Technology Transfer and System Integration for minimal production down-time. “Crafting CMO Solutions” is the WDPrx mission. We value our reputation as creative problem-solving specialists with flexible capabilities committed to client communication and success.

Contract Service Directory

    Related Content

    • Drug Development | Drug Discovery

    • Drug Development

    • Breaking News | Fill/Finish | Industry News | Vials
      Vetter to Invest in Collaborative Work Robots

      Vetter to Invest in Collaborative Work Robots

      Following a successful pilot project with a dual-arm robot in secondary packaging, the company is planning to purchase two additional robots.
      10.31.19


    • A Structured Approach for Spray-dried Dispersion Formulations and Process Development

      Tuesday, November 5th, 12:00 PM - 1:00 PM   A Structured Approach for Spray-dried Dispersion Formulations and Process Development Location: Partner Presentation Classroom 8, Exhibit Hall 234 Formulation and Quality…
      10.28.19

    • APIs
      Better Drug Manufacturing Strategies: Custom APIs

      Better Drug Manufacturing Strategies: Custom APIs

      Today’s biopharma companies are turning to their contractors for long-term collaboration and much higher levels of support.
      Tom Wilson, VP, Global Contract Manufacturing Leader, Pfizer CentreOne 10.15.19

    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19


    • Contracting And Outsourcing Agenda

      Conference Speakers & Topics (please check back for details) Wednesday, September 25th: Registration and exhibitor setup: 7:30 p.m.- 8:30 p.m. A Reception will be held 8pm – 9pm Sponsored by Federal Equipment Thursday,…
      09.17.19

    • Cytotoxics and High Potency Manufacturing
      API to ADC: A Journey Through High Potency

      API to ADC: A Journey Through High Potency

      This class of compounds represents a major advance in oncology research and treatment application.
      Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19

    • Ophthalmic Drug Delivery for Retinal Disorders

      Ophthalmic Drug Delivery for Retinal Disorders

      This whitepaper explores the development and manufacturing considerations associated with ophthalmic drug delivery, with a focus on retinal disorders.


    • Pharma Packaging Solutions Expanding Capacity and Services

      Pharma Packaging Solutions Expanding Capacity and Services

      Investments over $2.7 million were made in several areas including additional portable serialization and aggregation equipment.

    • Collaborations & Alliances | Drug Development
      Gilead and Nurix to Collaborate on Novel Therapies

      Gilead and Nurix to Collaborate on Novel Therapies

      Consisting of targeted protein degradation drugs for patients with cancer and other challenging diseases
      06.20.19